Cancer types
  • Lung
Title of study
Elderly with locally advanced Lung cancer: Deciding through geriatric Assessment on the oPtimal Treatment strategy
Version Number
Approval Date 
1.3, 24 February 2016
Short Title
Eldapt
Study site
Principle Investigator
Dr. J. van Loon (MAASTRO), dr. A. Dingemans (MUMC), dr. M. Janssen (VieCuri)
Investigator Maastro
Dr. J. van Loon
Sponsor
NVALT
Trial registry
Objectives 

The primary objective of the project is to compare concurrent and sequential RCHT with respect to quality-adjusted survival (QAS) of elderly patients (≥75 years) with stage III NSCLC. Overall survival Quality-adjusted survival (QAS)

Primary Endpoint 
Secondary Endpoints 

• To perform a geriatric assessment in stage III NSCLC patients to distinguish patients fit enough to undergo intensified treatment and to develop a reliable and clinically applicable geriatric screening instrument to guide treatment decisions in stage III NSCLC;
• To compare concurrent and sequential RCHT with respect to overall and progression free survival, overall and lung-cancer specific quality of life (QoL) and preservation of independence
• To compare cost-effectiveness of sequential and concurrent RCHT for elderly patients with stage III NSCLC